Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Effects of red-cell storage duration on patients undergoing cardiac surgery.

Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, Granger S, Bennett-Guerrero E, Blajchman MA, Scavo V, Carson JL, Levy JH, Whitman G, D'Andrea P, Pulkrabek S, Ortel TL, Bornikova L, Raife T, Puca KE, Kaufman RM, Nuttall GA, Young PP, Youssef S, Engelman R, Greilich PE, Miles R, Josephson CD, Bracey A, Cooke R, McCullough J, Hunsaker R, Uhl L, McFarland JG, Park Y, Cushing MM, Klodell CT, Karanam R, Roberts PR, Dyke C, Hod EA, Stowell CP.

N Engl J Med. 2015 Apr 9;372(15):1419-29. doi: 10.1056/NEJMoa1414219.

2.

Evaluation of the minimum volume of salvage blood required for the successful use of two different autotransfusion devices.

Baumann C, Lamesic G, Weiss M, Cushing MM, Haas T.

Paediatr Anaesth. 2015 Mar;25(3):258-64. doi: 10.1111/pan.12535. Epub 2014 Sep 30.

PMID:
25267461
3.

Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.

Arinsburg SA, Shaz BH, Westhoff C, Cushing MM.

Am J Hematol. 2012 May;87(5):525-8. doi: 10.1002/ajh.23111. Epub 2012 Feb 17. Review.

PMID:
22345051
4.

A survey to assess transfusion medicine education needs for clinicians.

Arinsburg SA, Skerrett DL, Friedman MT, Cushing MM.

Transfus Med. 2012 Feb;22(1):44-9; quiz 49-51. doi: 10.1111/j.1365-3148.2011.01118.x. Epub 2011 Dec 5.

PMID:
22141339
5.

Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.

Arinsburg SA, Skerrett DL, Karp JK, Ness PM, Jhang J, Padmanabhan A, Gibble J, Schwartz J, King KE, Cushing MM.

Transfusion. 2012 May;52(5):946-52. doi: 10.1111/j.1537-2995.2011.03403.x. Epub 2011 Nov 7.

PMID:
22060800
6.

The significance of a positive DAT in thalassemia patients.

Arinsburg SA, Skerrett DL, Kleinert D, Giardina PJ, Cushing MM.

Immunohematology. 2010;26(3):87-91.

PMID:
21214294
7.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Tormey CA, Peddinghaus ME, Erickson M, King KE, Cushing MM, Bill J, Goodrich T, Snyder EL.

Transfusion. 2010 Feb;50(2):471-7. doi: 10.1111/j.1537-2995.2009.02412.x. Epub 2009 Oct 5.

PMID:
19804570
8.

Oxygen therapeutics: perfluorocarbons and blood substitute safety.

Cohn CS, Cushing MM.

Crit Care Clin. 2009 Apr;25(2):399-414, Table of Contents. doi: 10.1016/j.ccc.2008.12.007. Review.

PMID:
19341916
9.

Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.

Webber BA, Cushing MM, Li S.

Int J Clin Exp Pathol. 2008 Jan 1;1(2):124-33.

10.

Oxygen therapeutics: pursuit of an alternative to the donor red blood cell.

Ness PM, Cushing MM.

Arch Pathol Lab Med. 2007 May;131(5):734-41. Review.

PMID:
17488158
11.

Fatal West Nile virus encephalitis in a renal transplant recipient.

Cushing MM, Brat DJ, Mosunjac MI, Hennigar RA, Jernigan DB, Lanciotti R, Petersen LR, Goldsmith C, Rollin PE, Shieh WJ, Guarner J, Zaki SR.

Am J Clin Pathol. 2004 Jan;121(1):26-31.

12.

The psychoanalytic treatment of a man suffering with ulcerative colitis.

CUSHING MM.

J Am Psychoanal Assoc. 1953 Jul;1(3):510-8. No abstract available.

PMID:
13061351
13.

A concept of the genesis of hostility.

CUSHING JG, CUSHING MM.

Bull Menninger Clin. 1949 May;13(3):94-9. No abstract available.

PMID:
18144376
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk